Effect of inflammation on prostate cancer incidence and dutasteride efficacy in the Reduction by Dutasteride of Cancer Events (REDUCE) study. Background: PLCO is a large-scale, randomized study to ...

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

False positive PSA results cause unneeded treatments. An expert panel has recommended against routine blood screening for prostate cancer, in a report published Wednesday in The BMJ. The panel, ...

Paclitaxel Decreases the Interstitial Fluid Pressure and Improves Oxygenation in Breast Cancers in Patients Treated With Neoadjuvant Chemotherapy: Clinical Implications From our prostate cancer ...

The budget impact model used the most recent AUA recommendation for prostate cancer screening. 3 Three PSA testing strategies were compared: (1) PSA, (2) %fPSA, and (3) the index. Strategies (1) and ...

Biparametric magnetic resonance imaging may offer advantages over PSA testing and ultrasonography by detecting more clinically significant prostate cancers without increasing the number of men advised ...

A recent BBC investigation questioned the accuracy of prostate-specific antigen (PSA) self-tests – rapid at-home tests for men worried about prostate cancer. The BBC analysed five of these tests using ...

Credit: Getty Images Study supports the role of PSMA PET for risk stratifying patients with clinically node-positive disease before radical prostatectomy, along with mpMRI and clinical parameters.

A considerable proportion of men undergoing radical prostatectomy (RP) for prostate cancer will experience postoperative biochemical progression. Appropriate treatment for these men hinges on the ...

UCB has announced that the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending extending the European Union marketing ...